FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...
The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...
The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version. In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some ...
The G4 CGM from Dexcom (above) looks similar to an earlier generation of Apple's iPod (below). It is fitting, in more ways than one, to compare the firm’s technology to GPS systems. In addition to ...
The FDA has approved updat- ed, more accurate software for the Dexcom G4 Platinum pediatric continuous glucose monitoring (CGM) system. The approval, granted May 22, 2015, reflects soft-ware changes ...
Please provide your email address to receive an email when new articles are posted on . Dexcom Inc. issued a recall of its continuous glucose monitoring systems because the audible alarm may not ...
Dexcom's g4 PLATINUM Continuous Glucose Monitoring System will be able to integrate with the Apple Watch. Users of Dexcom’s G4 PLATINUM Continuous Glucose Monitoring (CGM) System have something to ...
Simultaneous use of two popular continuous glucose monitoring (CGM) sensors revealed clear differences in their accuracy and in patient-rated treatment experiences, including ease of use, feelings of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results